Cyberknife radiosurgery is a time-efficient, fast-responding therapeutic option for choroidal metastases.

Meta-analysis: Cyberknife dynamic respiratory motion management for moving targets reduces toxicity in comparison to other, less accurate techniques.

Cyberknife robotic radiosurgery can accomplish excellent local control for visceral and lymph node metastases of renal cell carcinoma, with minimal...

Multicenter study: Critical, intramedullary spinal cord metastases can be treated safely and effectively with Cyberknife.

Persistent acromegaly after resection of pituitary adenomas can be successfully treated with Cyberknife radiosurgery.

Rare retinal vasoproliferative tumors can also be treated effectively with Cyberknife.

"International Radiosurgery Oncology Consortium for Kidney" (IROCK): Large, inoperable renal cell carcinoma are also suitable for radiosurgery.

Risk factors for radionecrosis after intracranial radiosurgery were determined in a meta-analysis.

A multicentric study demonstrates effectiveness of Cyberknife Radiosurgery for glomus jugulare tumors.

Locally recurrent prostate cancer after radical prostatectomy is suitable for Cyberknife radiosurgery in selected cases.

Artificial intelligence identifies promising beam directions and improves quality of prostate plans.